CentraSight® Offers Hope for People with End-stage AMD

People of all ages — particularly those age 60 and older — should have an annual eye exam that includes dilation of pupils to detect for signs of age-related macular degeneration (AMD). Although it’s considered an incurable eye disease, certain treatments for AMD may delay its progression and help prevent severe vision loss.

At the office of Retina Group of Washington – Maryland – Chevy Chase our team of skilled professionals is trained in the diagnosis and treatment of end-stage AMD and, using advanced technologies, we can help improve your eye vision and quality of life.

AMD occurs when there is damage to the light sensing cells of the macula, the small area at the center of the eye’s retina responsible for most of our central vision. The disease is progressive and in its end stages, the macula reaches a point where central vision is lost in both eyes, making it difficult to perform everyday tasks. The CentraSight® treatment program could help improve your vision and reconnect you to the things in life you love to see and do.

CentraSight® is an FDA-approved medical telescope, about the size of a pea, which is implanted inside the eye to reduce the effects of the central vision blind spot caused by the disease. The telescope implant projects the objects that you’re trying to see onto the healthy area of the light-sensing retina that has not degenerated.

After a thorough examination and testing, we will discuss with you if you’re likely to benefit from the CentraSight treatment program. If so, our tests will indicate which eye should be treated and what your vision may be like after the telescope is inserted.

Optimal vision is our top priority

At the office of Retina Group of Washington – Maryland – Chevy Chase, we’re dedicated to providing the highest quality of skilled and compassionate eye care. If you are experiencing symptoms of end-stage AMD, contact us immediately. For more information on our office and the many services that we provide, give us a call today.

ForeseeHome™ Empowers You to Monitor Your AMD

As people age, many people start having trouble with their eyesight. One of the most common conditions that affects them is AMD – age-related macular degeneration – the leading cause of severe, irreversible vision loss in people over age 60.

Fortunately, advanced technologies are allowing for greater monitoring and enhanced vision capabilities for people with a certain kinds of AMD. At the office of Retina Group of Washington – Maryland – Chevy Chase, our team of highly-skilled eye professionals will explain all of the options available to you. Among them: ForeseeHome,™ home monitoring device clinically proven to identify even the smallest changes in your vision.

AMD has two types: wet and dry. Wet macular degeneration is a chronic eye disorder that causes blurred vision or a blind spot in your visual field. It’s generally caused by abnormal blood vessels that leak fluid or blood into the macula, the part of the eye’s retina responsible for central vision. Dry macular degeneration, which often progresses to the wet form, is due to the thinning of the macula, is more common but less severe. Early detection is the best way to catch the progression from dry AMD to wet AMD.

ForeseeHome® allows us to detect signs of AMD progression earlier, and help preserve vision in patients at risk by beginning prompt treatment. When used daily, the ForeseeHome Monitor can identify vision changes even before the patient notices them, giving us the ability to review test results consistently and address any problems quickly.

Your vision is our top priority

At the office of Retina Group of Washington – Maryland – Chevy Chase, we’re dedicated to providing the highest quality of skilled and compassionate eye care. For more information on our office and the many services that we provide, give us a call today.